Cargando…

Moving HER2-low breast cancer predictive and prognostic data from clinical trials into the real world

Background: Previous data, mostly from clinical trials, reported that HER2-low status is associated with low pathological complete response (pCR), and favourable prognosis. Since these findings suggest the existence of an additional breast cancer subtype, we questioned if the predictive/prognostic v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Cosimo, Serena, La Rocca, Eliana, Ljevar, Silva, De Santis, Maria Carmen, Bini, Marta, Cappelletti, Vera, Valenti, Marta, Baili, Paolo, de Braud, Filippo G., Folli, Secondo, Scaperrotta, Gianfranco, Volpi, Chiara, Vingiani, Andrea, Vernieri, Claudio, Verderio, Paolo, Miceli, Rosalba, Pruneri, Giancarlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549400/ https://www.ncbi.nlm.nih.gov/pubmed/36225259 http://dx.doi.org/10.3389/fmolb.2022.996434

Ejemplares similares

Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancer
por: Silvestri, Marco, et al.
Publicado: (2022)

Circulating Tumor Cell Clusters Are Frequently Detected in Women with Early-Stage Breast Cancer
por: Reduzzi, Carolina, et al.
Publicado: (2021)

Targeted-Gene Sequencing to Catch Triple Negative Breast Cancer Heterogeneity before and after Neoadjuvant Chemotherapy
por: Di Cosimo, Serena, et al.
Publicado: (2019)

Early stage breast cancer follow-up in real-world clinical practice: the added value of cell free circulating tumor DNA
por: La Rocca, E., et al.
Publicado: (2022)

Direct and indirect effects of COVID-19 on short-term mortality of breast cancer patients
por: Di Cosimo, Serena, et al.
Publicado: (2023)

Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapy
por: Ortolan, E., et al.
Publicado: (2021)

Neoadjuvant eribulin mesylate following anthracycline and taxane in triple negative breast cancer: Results from the HOPE study
por: Di Cosimo, Serena, et al.
Publicado: (2019)

Occurrence of breast‐cancer–related lymphedema after reverse lymphatic mapping and selective axillary dissection versus standard surgical treatment of axilla: A two‐arm randomized clinical trial
por: Gennaro, Massimiliano, et al.
Publicado: (2022)

Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate Cancer
por: Doldi, Valentina, et al.
Publicado: (2022)

End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO
por: Di Cosimo, Serena, et al.
Publicado: (2023)

T‐cell immune response after mRNA SARS‐CoV‐2 vaccines is frequently detected also in the absence of seroconversion in patients with lymphoid malignancies
por: Marasco, Vincenzo, et al.
Publicado: (2021)

Comprehensive transcriptomic analysis to identify biological and clinical differences in cholangiocarcinoma
por: Silvestri, Marco, et al.
Publicado: (2023)

Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications
por: Zattarin, Emma, et al.
Publicado: (2020)

Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients
por: Ligorio, Francesca, et al.
Publicado: (2021)

A combination of extracellular matrix‐ and interferon‐associated signatures identifies high‐grade breast cancers with poor prognosis
por: Lecchi, Mara, et al.
Publicado: (2021)

A three-gene signature marks the time to locoregional recurrence in luminal-like breast cancer
por: Chiodoni, C., et al.
Publicado: (2023)

Nonrestrictive diet does not increase infections during post-HSCT neutropenia: data from a multicenter randomized trial
por: Stella, Federico, et al.
Publicado: (2023)

Combination of Baseline LDH, Performance Status and Age as Integrated Algorithm to Identify Solid Tumor Patients with Higher Probability of Response to Anti PD-1 and PD-L1 Monoclonal Antibodies
por: Cona, Maria Silvia, et al.
Publicado: (2019)

Basic fibroblast growth factor and vascular endothelial growth factor serum levels in breast cancer patients and healthy women: useful as diagnostic tools?
por: Granato, Anna Maria, et al.
Publicado: (2004)

Detection of Genomically Aberrant Cells within Circulating Tumor Microemboli (CTMs) Isolated from Early-Stage Breast Cancer Patients
por: Silvestri, Marco, et al.
Publicado: (2021)

Circulating miRNAs as Novel Non-Invasive Biomarkers to Aid the Early Diagnosis of Suspicious Breast Lesions for Which Biopsy Is Recommended
por: Giussani, Marta, et al.
Publicado: (2021)

Targeted RNA-sequencing analysis for fusion transcripts detection in tumor diagnostics: assessment of bioinformatic tools reliability in FFPE samples
por: Capone, Iolanda, et al.
Publicado: (2022)

Psychosocial factors associated with workability after surgery in cancer survivors: An explorative study
por: Silvaggi, Fabiola, et al.
Publicado: (2023)

Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer
por: Vernieri, Claudio, et al.
Publicado: (2022)

Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin
por: Zattarin, Emma, et al.
Publicado: (2022)

The P.I.N.K. Study Approach for Supporting Personalized Risk Assessment and Early Diagnosis of Breast Cancer
por: Franchini, Michela, et al.
Publicado: (2021)

Impact of Metformin on Systemic Metabolism and Survival of Patients With Advanced Pancreatic Neuroendocrine Tumors
por: Vernieri, Claudio, et al.
Publicado: (2019)

A novel circulating tumor cell subpopulation for treatment monitoring and molecular characterization in biliary tract cancer
por: Reduzzi, Carolina, et al.
Publicado: (2019)

Detection of Circulating Tumour Cells in Urothelial Cancers and Clinical Correlations: Comparison of Two Methods
por: Fina, Emanuela, et al.
Publicado: (2017)

Commentary: SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China
por: Di Cosimo, Serena, et al.
Publicado: (2020)

Microenvironment and tumor inflammatory features improve prognostic prediction in gastro‐entero‐pancreatic neuroendocrine neoplasms
por: Milione, Massimo, et al.
Publicado: (2019)

COVID‐19 outbreak in Lombardy: Impact on reducing solid cancer diagnoses in 2020
por: Trama, Annalisa, et al.
Publicado: (2022)

Molecular Tumor Board as a Clinical Tool for Converting Molecular Data Into Real-World Patient Care
por: Vingiani, Andrea, et al.
Publicado: (2023)

Effects of solar irradiance noise on a complex marine trophic web
por: Grimaudo, Roberto, et al.
Publicado: (2022)

Prevalence of BRCA homopolymeric indels in an ION Torrent-based tumour-to-germline testing workflow in high-grade ovarian carcinoma
por: Azzollini, Jacopo, et al.
Publicado: (2023)

Patient-reported outcome measurements in post-mastectomy implant-based breast reconstruction and radiotherapy: Analysis of BREAST-Q data
por: Sala, Laura, et al.
Publicado: (2022)

Clinical performance of contrast-enhanced spectral mammography in pre-surgical evaluation of breast malignant lesions in dense breasts: a single center study
por: Bozzini, Anna, et al.
Publicado: (2020)

Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model
por: Azzollini, Jacopo, et al.
Publicado: (2022)

How to reprogram microglia toward beneficial functions
por: Fumagalli, Marta, et al.
Publicado: (2018)

TNF Production and Release from Microglia via Extracellular Vesicles: Impact on Brain Functions
por: Raffaele, Stefano, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t6cbavul656ugchha2ahgeeg96